NovaSight Overview

Founded 2016
Status Private
Employees 15
Latest Deal Type Early Stage VC
Latest Deal Amount $2.27M
Latest Deal Amount
Investors 2

NovaSight General Information


Developer of an AI-based eye-cure technology designed to diagnose and treat pediatric vision disorders. The company's technology portfolio includes CureSight, a plug-in screen with an eye tracker and glasses to treat Lazy Eye by differentiating the content that each eye sees and EyeSwift, an automated, portable, and easy-to-use eye-tracking system for monitoring the patient's eye movements, enabling patients to treat amblyopia while watching movies rather than following existing recommendation of wearing an eye-patch for treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 1 Hayarden Street
  • Airport City 7019801
  • Israel
+972 00-000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NovaSight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC $2.27M 00.000 Completed Generating Revenue

NovaSight Executive Team (3)

Name Title Board Seat Contact Info
Ran Yam Co-Founder & Chief Executive Officer
Danny Oz Co-Founder & Chief Technology Officer
Oren Yehezkel Chief Scientific Officer

NovaSight Investors (2)

To view NovaSight‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Club 100 plus Angel Group Minority 000 0000 000000 0
Rimonci Capital Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial